Pediatrix. (MD) Reports Q1 EPS Beat

Pediatrix Medical Group, Inc. (NYSE:MD) is one of the 8 Best Small Cap US Stocks to Buy.

On May 5, 2026, Pediatrix Medical Group, Inc. (NYSE:MD) reported Q1 adjusted EPS of 44c, versus the consensus estimate of 38c. Revenue totaled $476M, versus the consensus estimate of $465.82M. Same-unit revenue from net reimbursement-related factors increased 4.4% year over year. CEO Mark Ordan said first-quarter operating results exceeded expectations, driven by top-line growth, while adding that the company’s priorities for 2026 remain centered on supporting hospital partners through quality-focused care delivery. Ordan also said Pediatrix believes its strong cash flow generation and balance sheet position the company to pursue additional opportunities moving forward. Pediatrix Medical Group, Inc. (NYSE:MD) reaffirmed its FY26 adjusted EBITDA outlook of $280M-$300M.

On April 20, 2026, Jefferies analyst Jack Slevin raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $27 from $24 while maintaining a Buy rating. The firm said recent underperformance across healthcare services stocks reflected investor concerns tied to Q1 patient volumes, though Jefferies questioned whether consensus expectations fully accounted for weather-related disruptions caused by winter storms in Southern and East Coast markets.

Pediatrix. (MD) Reports Q1 EPS Beat

Samuel Borges Photography/Shutterstock.com

Meanwhile, Truist raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $23 from $21 while maintaining a Hold rating as part of a broader preview of healthcare services earnings. Truist said it remains constructive on the sector given strong demand trends, supportive reimbursement conditions, defensive characteristics, and continued benefits tied to AI, automation, and connectivity initiatives.

Pediatrix Medical Group, Inc. (NYSE:MD) provides newborn, maternal-fetal, and pediatric subspecialty healthcare services in the United States.

While we acknowledge the risk and potential of MD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.